NYLTHRQ is a peptide that specifically disrupts the interaction between soluble VEGFR1 isoform i13 and β1 integrin, leading to the inhibition of VEGFR1 and VEGFR2 activation. This modulation results in a reduction of cancer cell proliferation, highlighting its potential in cancer therapeutics. NYLTHRQ is particularly relevant for research focused on tumors, including lung squamous cell carcinoma.
NYLTHRQ is a peptide that specifically disrupts the interaction between soluble VEGFR1 isoform i13 and β1 integrin, leading to the inhibition of VEGFR1 and VEGFR2 activation. This modulation results in a reduction of cancer cell proliferation, highlighting its potential in cancer therapeutics. NYLTHRQ is particularly relevant for research focused on tumors, including lung squamous cell carcinoma.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: